| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.063 | 0.05 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.062 | 0.05 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.05 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.079 | 0.05 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.05 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | -0.081 | 0.05 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.079 | 0.05 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.078 | 0.05 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.05 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | 0.072 | 0.05 |